SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 163 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,996,841 | +9.5% | 206,394 | +57.8% | 0.01% | -20.0% |
| Q2 2023 | $2,736,765 | +219.1% | 130,758 | +222.0% | 0.01% | +150.0% |
| Q1 2023 | $857,704 | +17.3% | 40,611 | -3.5% | 0.00% | -33.3% |
| Q1 2022 | $731,000 | +136.6% | 42,073 | +101.8% | 0.01% | +20.0% |
| Q2 2020 | $309,000 | – | 20,852 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 8,076 | $174,522 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 46 | $994 | 0.00% |